News

Do I have a Case?

Do I Have a Case?

FDA orders recall of Custom Ultrasonics Automated Endoscope Reprocessors

Healthcare facilities advised ceasing using System 83 Plus endoscope reprocessors

The Food and Drug Administration (FDA) has ordered a recall of Custom Ultrasonics’ System 83 Plus automated endoscope reprocessors (AER), accusing the company of violating federal regulations. An April 2015 inspection of Custom Ultrasonics’ Ivyland, Pennsylvania facility revealed the company’s failure to validate its System 83 Plus AER’s ability to disinfect endoscopes, the recall notes.

Automated endoscope reprocessors are Class II medical devices used to clean and sterilize endoscopes between procedures. Endoscopes are long, flexible medical devices with a light at the end user in minimally invasive procedures to look inside patients’ bodies.

The endoscope’s flexible design can make it very difficult to clean. Residual bodily fluids may leave behind bacteria in the channels of the endoscope if not properly reprocessed. If endoscopes are not adequately sterilized after use, patients may be put at risk of contracting severe, possibly life-threatening infections.

Endoscopy patients at risk for antibiotic-resistant bacteria exposure

Patients undergoing routine medical procedures like endoscopic retrograde cholangiopancreatography (ERCP) can be exposed to antibiotic-resistant bacteria known as carbapenem-resistant Enterobacteriaceae (CRE).

CRE is the same type of drug-resistant bacteria linked to the deadly “superbug” outbreak at UCLA Medical Center and Virginia Mason Hospital in Seattle, Washington. Both cases involved improperly reprocessed Olympic Medical Q180V endoscopes.

The FDA recall affects approximately 2,800 Custom Ultrasonics AERs in the U.S. Custom Ultrasonics has seven days to provide the FDA with a recall proposal. The FDA recall affects the following Custom Ultrasonics AERs:

  • System 83 Plus
  • System 83 Plus 2
  • System 83 Plus 9

Custom Ultrasonics has a long regulatory history with the FDA. In 2007, the FDA slapped the AER maker with a Consent Decree of Permanent Injunction (Consent Decree), barring Custom Ultrasonics from distributing medical devices.

After being allowed to resume operations by the FDA in 2007, Custom Ultrasonics was again hit with injunctions to cease production in 2012 and 2013. The 83 Plus AER system was the only medical device Custom Ultrasonics had been allowed to produce, up until now.

Contact D.C. product liability attorneys

If you or a loved one contracted a serious infection after undergoing an endoscopic procedure, it may be because the endoscope was not properly sterilized prior to use. The product liability attorneys of The Cochran Firm, D.C. have a team of in-house registered nurses and investigators ready to help you get answers. Contact one of our attorneys for your free legal consultation.

Newsletter

Stay informed with our most recent news, events and employment opportunities.
Group Recommend
Contact Us
WASHINGTON, DC
1666 K Street NW
Suite 1150
Washington, DC 20006
1-800-THE-FIRM
202-589-1500
1-800-THE-FIRM
Have a question?
Get in Touch.
The Cochran Firm handles Medical Malpractice, Catastrophic Personal Injuries, Motor Vehicle Accidents & Wrongful Death Claims for clients throughout the United States of America. The information on this website does not constitute legal advice nor form an attorney-client relationship. Please contact The Cochran Firm today to schedule a free consultation.
© 2024 Copyright The Cochran Firm DC.
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram